Separation of Diastereomeric Chiral Metabolites Using UPC 2 MS/MS Chester L. Bowen,1 Hermes Licea-Perez,1 Paul D. Rainville,2 Tom DiPillipo,2 Denise Heyburn,2 Robert S. Plumb,2 and Christopher Evans1 1 Bioanalytical Sciences and Toxicokinetics, PTS DMPK, GlaxoSmithKline, King of Prussia, PA, USA…
Key words
negligible, precision, bias, run, chiral, time, between, xevo, stereoisomer, clinical, stereoselective, metabolites, diastereomeric, dmpk, preclinical